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Results: In the following table.
*nt =non-typeable.
Conclusion: While PV7 serotypes have declined since
2000, in 2004 approximately 20% of the invasive isolates
from this study were from the seven vaccine types (4, 6B,
9 V, 14, 18C, 19F, 23F). In-patients and out-patients were
equally likely to carry PV7 serotypes. Serotype 19A was the
most common serotype in both in- and out-patients, which
is cause for concern as this serotype is often non-susceptible
to penicillin and erythromycin. In-patients were more likely
to carry non-typeable isolates, while equal percentages of
isolates from both groups were non-encapsulated. Contin-
ued monitoring of post-vaccine serotype trends will be vital
to the management of pneumococcal disease.
doi:10.1016/j.ijid.2010.02.480
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Background: Although the acute phase disease is well
described in leptospirosis, few studies have focused on the
follow up after Hospital discharge. Thus, our knowledge is
still insufﬁcient on how frequent are some late complica-
tions or what is the rate of remission of laboratory markers
of disease such kidney function tests, platelet count or liver
enzymes. We investigated the frequency of clinical mani-
festations and the laboratory test abnormalities in patients
who had severe leptospirosis at the ambulatory care level,
after discharge.
Methods: Patients who had severe disease requiring inpa-
tient were asked to return to the reference Hospital Emilio
Ribas after discharge. The mean interval between Hospi-
tal discharge and the ambulatory visit was 24.7± 11.1 days
(mean± SD). Clinical and laboratory data were collected.
Results: Thirty-nine consecutive patients were enrolled.
Most patients were males (85%, 35/39) and the mean age
was 35.5± 17.6 years. The mean period of hospitalization
was 11.5± 7.0 days. During hospitalization, the patients
presented the following clinical manifestations or complica-
tions: pulmonary involvement (26%, 10/39), jaundice (59%,
23/39), renal failure (44%, 17/39, six requiring dialysis), and
shock (8%, 3/39). Twelve (31%) required ICU support. The
following abnormal laboratory test results were obtained in
the acute phase disease: serum creatinine > 3mg/dl (36%,
14/39), Bilirubin > 6mg/dl (41%, 16/39), platelet count <
70,000 units per mm3 (21%, 8/39), aspartate aminotrans-
ferase > 100 UI/L (29%, 9/31) and alanine aminotransferase
> 100 UI/L (26%, 8/31). At the ambulatory visit, only
minor complaints were reported: weakness (n = 7), headache
(n = 3), myalgia (n = 1) while jaundice persisted three cases.
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veitis was not detected. No patient had platelet count
ower than 150,000 units/mm3. No patient had serum creati-
ine > 3mg/dl or serum Bilirubin > 6mg/dl at the ambulatory
isit. Serum Alanine aminotransferase > 100 UI/L persisted
n two patients.
Conclusion: Our results conﬁrm the general concept that
eptospirosis usually resolves without long lasting effects.
urther studies are recommended to evaluate if elevation of
iver enzymes, a laboratory test abnormality already associ-
ted with poor prognosis in previous studies, improves in a
ower rate when compared to other manifestations.
oi:10.1016/j.ijid.2010.02.481
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he detection of antibodies directed against speciﬁc anti-
ens of Borrelia burgdorferi sensu lato (B. burgdorferi
.s., B. afzelii, B. garinii, B. spielmanii) in patients with
orreliosis in Eastern Poland
. Tokarska-Rodak1, H. Fota-Markowska1,∗, M.
ozioł—Montewka1, F. S´miechowicz1, B. Gajownik2, M.
rokop3, R. Modrzewska1
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Background: The most common Borrelia genospecies
nvolved in the etiology of Lyme disease in Eastern Europe
re: B. burgdorferi s.s., B. garinii, and B. afzelii. However,
he role of other genospecies including B. spielmanii has
lso been suggested. In view of a paucity of epidemiologic
ata concerning the role of B. spielmanii as the potential
ausative agent of Lyme disease in Poland, investigation
owards identiﬁcation of patients with serologic evidence
f infection caused by this Borrelia genospecies was under-
aken.
Methods: The study group comprised 41 patients from
astern Poland with borreliosis (age range: 19-65 yrs).
etection of IgG and IgM antibodies to B. burgdorferi s.l. was
erformed using test (Mikrogen) which included the follow-
ng antigens for IgM and IgG: OspC and p18 (B. burgdorferi
.s., B. afzelii, B. garinii, B. spielmanii), VlsE, p100, p58,
41, p39, and OspA.
Results: The results of the study indicate that the simul-
aneous presence of IgM antibodies against OspC protein
haracteristic of all four genospecies (B. burgdorferi s.s.,
. afzelii, B. garinii, and B. spielmanii) was detected in
6 patients with clinical manifestations of borreliosis. The
resence of IgM antibodies to OspC antigen of B. spielmanii
ccompanied by negative results for the presence of anti-
odies against antigens of the remaining genospecies was
etected in one patient.
The IgG antibodies against B. burgdorferi s.l. were
bserved with varying frequency:anti- VlsE in 22 patients,
anti-OspC for four genospecies: B. burgdorferi s.s., B.
afzelii, B. garinii and B. spielmanii in 9 patients,
anti-p18 for single genospecies, more often for B. afzelii
(4 patients) and B. spielmanii (5 patients).
